Investors Sue Biopharma Co. After Clinical Trial Data Toss

By Emilie Ruscoe · January 22, 2024, 9:30 PM EST

Biopharmaceutical company BioVie and three of its executives are facing an investors' proposed class action after "suspected coordinated improprieties" led the company to toss data for over 80% of the subjects...

To view the full article, register now.